4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data
Data up to Jan 2025
Total Citations Per Year
Abstract
References (36)
Bedside technics for the evaluation of ventricular function in man
1969 • 608 citations
Phase II evaluation of adriamycin in human neoplasia
1973 • 414 citations
Dose response evaluation of adriamycin in human neoplasia
1977 • 389 citations
Clinical management of advanced gastrointestinal cancer
1975 • 212 citations
Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone
1975 • 194 citations
Combination chemotherapy and adriamycin in patients with advanced breast cancer.A Southwest Oncology Group study
1976 • 151 citations
Experimental evaluation of anthracycline analogs.
1979 • 118 citations
Survival and response to chemotherapy for advanced colorectal adenocarcinoma. An eastern cooperative oncology group report
1980 • 117 citations
Changes of activity of daunorubicin, adriamycin and stereoisomers following the introduction or removal of hydroxyl groups in the amino sugar moiety
1977 • 83 citations
12th International Congress of Chemotherapy
1980 • 79 citations
Relationship between activity and amino sugar stereochemistry of daunorubicin and adriamycin derivatives.
1976 • 75 citations
Toxic and Therapeutic Activity of 4'-Epi-Doxorubicin
1982 • 68 citations
Controlled evaluation of adriamycin (NSC-123127) in patients with disseminated breast cancer.
1974 • 62 citations
Induction of malignant transformation and mutagenesis in cell cultures by cancer chemotherapeutic agents
1977 • 58 citations
Preliminary phase I study of 4'-epi-adriamycin.
1979 • 53 citations
Preliminary Clinical Experience with 4’-Epidoxorubicin in Advanced Human Neoplasia
1980 • 51 citations
Studies on the mode of interaction of 4'-epi-adriamycin and 4-demethoxy-daunomycin with DNA
1978 • 43 citations
Studies on the comparative distribution and biliary excretion of doxorubicin and 4'-epi-doxorubicin in mice and rats.
1980 • 38 citations
Phase II clinical evaluation of 4'-epi-doxorubicin.
1983 • 34 citations
ChemInform Abstract: SYNTHESIS AND ANTITUMOR PROPERTIES OF NEW GLYCOSIDES OF DAUNOMYCINONE AND ADRIAMYCINONE
1975 • 29 citations
Phase II clinical trial of cis dichlorodiammine platinum (Cis DDP) in metastatic brain tumors
1982 • 28 citations
Phase-II clinical trial of 4′-epi-doxorubicin in metastatic solid tumors
1983 • 28 citations
Relationship between the Effect on Calcium Turnover and Early Cardiotoxicity of Doxorubicin and 4'-EPI-Doxorubicin in Guinea Pig Heart Muscle
1980 • 27 citations
Effect of 4'-doxorubicin analogs on heterotransplantation of human tumors in congenitally athymic mice.
1981 • 24 citations
Adriamycin (NSC-123127) therapy for advanced gastrointestinal cancer.
1975 • 21 citations
A phase of I trial of 4'-epi-Adriamycin.
1981 • 20 citations
Phase II study of 4'-epi-doxorubicin in metastatic renal cancer.
1982 • 17 citations
Determination of 4′-epidoxorubicin and its 13-dihydro derivative in human plasma by high-performance liquid chromatography with fluorescence detection
1982 • 17 citations
Phase II Study of 4'Epi-Doxorubicin
1982 • 15 citations
UICC Conference on Clinical Oncology
1980 • 14 citations
Randomized phase II trial of rubidazone and adriamycin in women with advanced breast cancer.
1979 • 11 citations
Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer.
1978 • 9 citations
Preliminary echocardiographic and polygraphic evaluation of cardiac toxicity of 4'-epi-doxorubicin.
1983 • 9 citations
A phase II study of 4'-EPI-doxorubicin in advanced ovarian carcinoma
1982 • 9 citations
Carcinoma of renal parenchyma, renal pelvis and ureter—radiological diagnosis and treatment planning
1980 • 4 citations
Deleted Work
1955 • 0 citations
Cited By (0)
No citing papers found in database